Markets:

Overview

News

Currencies

International

Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

165.35 -0.33 (-0.20%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2

...

18 19 20 21 22 23 24 25 Next >

Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch ↗

September 15, 2023

Apple Inc (NASDAQ: AAPL) has appointed Tim Millet, a seasoned executive with a background in iPhone and Mac chip technology, to oversee its secretive team dedicated to developing a noninvasive blood...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 15, 2023

Friday's session saw 169 companies set new 52-week lows.

Via Benzinga

Why Insulet Stock Is Sinking Today ↗

September 07, 2023

Comments from Insulet's CEO at a major healthcare conference rattled investors.

Via The Motley Fool

What 12 Analyst Ratings Have To Say About Insulet ↗

September 06, 2023

Via Benzinga

What 8 Analyst Ratings Have To Say About Insulet ↗

August 10, 2023

Via Benzinga

Expert Ratings for Insulet ↗

May 30, 2023

Via Benzinga

Why Toro Are Trading Lower By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

September 07, 2023

Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 100% to $1.7909 after the company's subsidiary Champion Safe has been bombarded with calls from safe dealers and customers looking for...

Via Benzinga

Is It Time to Buy the S&P 500's 3 Worst-Performing August Stocks? ↗

September 07, 2023

The S&P 500 had a rare decline last month.

Via The Motley Fool

Topics Stocks

Insulet Earnings Perspective: Return On Capital Employed ↗

May 17, 2023

Via Benzinga

Dexcom Says It Won't Be The Biggest Loser In The Weight-Loss Battle — And Shares Soar ↗

September 06, 2023

Dexcom says the popularity of GLP-1 drugs won't hurt its continuous glucose monitors.

Via Investor's Business Daily

The 3 Most Promising Healthcare Stocks to Own Now ↗

September 01, 2023

These top healthcare stock picks are growing revenues by over 30% due to their game-changing medical device products.

Via InvestorPlace

Why Insulet Stock Rocked the Market Today ↗

August 30, 2023

The company's leader signals a giant vote of confidence in its future.

Via The Motley Fool

Hovnanian Enterprises, LexinFintech Holdings And Other Big Stocks Moving Higher On Wednesday ↗

August 30, 2023

U.S. stocks traded mixed, with the Dow Jones falling around 10 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

$1M Bet On Lyft? Check Out These 4 Stocks Insiders Are Buying ↗

August 30, 2023

Although U.S. stocks closed higher on Tuesday, there were a few notable insider trades.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

August 29, 2023

On Tuesday, 99 stocks hit new 52-week lows.

Via Benzinga

Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System in Germany

August 28, 2023

From Insulet Corporation

Via Business Wire

Morgan Stanley Maintains Equal-Weight Rating for Insulet: Here's What You Need To Know ↗

August 24, 2023

Via Benzinga

Insulet to Present at Upcoming Investor Conferences

August 24, 2023

From Insulet Corporation

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For August 21, 2023 ↗

August 21, 2023

Via Benzinga

NVIDIA To Rally Over 80%? Here Are 10 Other Analyst Forecasts For Monday ↗

August 21, 2023

Credit Suisse lowered the price target for The Walt Disney Company (NYSE: DIS) from $126 to $122. Credit Suisse analyst Douglas Mitchelson maintained an Outperforn rating. Disney shares gained 0.4% to...

Via Benzinga

JP Morgan Bullish On Insulet, Forecasts Robust Pump Market with Long Runway for Growth ↗

August 17, 2023

J.P.

Via Benzinga

Insulet Reports Second Quarter 2023 Revenue Increase of 32% Year-Over-Year (32% Constant Currency1)

August 08, 2023

From Insulet Corporation

Via Business Wire

Where to Invest $5,000 for the Next 20 Years ↗

August 02, 2023

These are high-growth opportunities investors should focus on for the long haul.

Via The Motley Fool

Just 8 S&P 500 Stocks Make The Cut In Goldman's 'Rule Of 10' Screens ↗

July 05, 2023

This elite eight meet long-term growth criteria for sales and earnings.

Via Investor's Business Daily

Insulet to Announce Second Quarter 2023 Financial Results on August 8, 2023

July 05, 2023

From Insulet Corporation

Via Business Wire

Goldman Sachs Reveals Winning Portfolio: 'Rule of 10' Unlocks S&P 500's Future Top Performers ↗

July 03, 2023

Via Benzinga

Insulet Celebrates One Year of Omnipod® 5 at the American Diabetes Association 83rd Scientific Sessions

June 22, 2023

From Insulet Corporation

Via Business Wire

Insulet Announces Omnipod® 5 Automated Insulin Delivery System is Now Available in the United Kingdom

June 20, 2023

From Insulet Corporation

Via Business Wire

Medtronic's EOflow Acquisition Will Not Impact Insulet's Omnipod' Insulin Pump In Near or Medium Term: Analyst ↗

May 26, 2023

Via Benzinga

AMD Stock, AI Play And New S&P 500 Member Lead 5 Stocks Near Buy Points ↗

May 06, 2023

AMD and a new S&P 500 member lead this weekend's watch list.

Via Investor's Business Daily

< Previous 1 2

...

18 19 20 21 22 23 24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.